Evidence map›Paper›PMID 35116947›Full record

ArticleTranslational cancer research2019

DNA hypermethylation of

Xinyan Liu, Haoran Bi, Anqi Ge, Tingting Xia, Jinming Fu, Yupeng Liu, Hongru Sun, Dapeng Li, Yashuang Zhao

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xinyan LiuDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Haoran BiDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Anqi GeDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Tingting XiaDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Jinming FuDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Yupeng LiuDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Hongru SunDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Dapeng LiDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Yashuang ZhaoDepartment of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150086, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAberrant DNA methylation could be used as biomarkers for colorectal cancer (CRC) detection and assessment of prognosis. The aim of our study was to investigate the potential possibility of

methodsWe followed up 298 sporadic postoperative CRC patients and detected

resultsThe

conclusions

Indexed as

Colorectal cancer (CRC)MALmethylationprognosis

Identifiers

PMID35116947
PMCPMC8799055
OpenAlexW4230648429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.